In this week's Briefing:

Compass Pathways Files for IPO
ATAI Launches MDMA Subsidiary
MindMed To Study LSD/MDMA Combo
Fears Rise About Instagram Ads for Ketamine
Canadian Psilocybin Patient Starts Treatment

In this week's Briefing: Compass Pathways Files for IPO ATAI Launches MDMA Subsidiary MindMed To Study LSD/MDMA Combo Fears Rise About Instagram Ads for Ketamine Canadian Psilocybin Patient Starts Treatment

Briefing: August 31st, The Biggest Go Public Yet

Report on Psychedelics is the leading source of independent data and intelligence for the emerging psychedelics industry.

Share Briefing: August 31st, The Biggest Go Public Yet

Sign up to save your podcasts

Briefing: August 31st, The Biggest Go Public Yet

Briefing: August 31st, The Biggest Go Public Yet